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Adherence of Helicobacter pylori to inflamed gastric mucosa is dependent on the sialic acid–binding adhesin (SabA)
and cognate sialylated/fucosylated glycans on the host cell surface. By in situ hybridization, H. pylori bacteria were
observed in close association with erythrocytes in capillaries and post-capillary venules of the lamina propria of gastric
mucosa in both infected humans and Rhesus monkeys. In vivo adherence of H. pylori to erythrocytes may require
molecular mechanisms similar to the sialic acid–dependent in vitro agglutination of erythrocytes (i.e., sialic acid–
dependent hemagglutination). In this context, the SabA adhesin was identified as the sialic acid–dependent
hemagglutinin based on sialidase-sensitive hemagglutination, binding assays with sialylated glycoconjugates, and
analysis of a series of isogenic sabA deletion mutants. The topographic presentation of binding sites for SabA on the
erythrocyte membrane was mapped to gangliosides with extended core chains. However, receptor mapping revealed
that the NeuAca2–3Gal-disaccharide constitutes the minimal sialylated binding epitope required for SabA binding.
Furthermore, clinical isolates demonstrated polymorphism in sialyl binding and complementation analysis of sabA
mutants demonstrated that polymorphism in sialyl binding is an inherent property of the SabA protein itself. Gastric
inflammation is associated with periodic changes in the composition of mucosal sialylation patterns. We suggest that
dynamic adaptation in sialyl-binding properties during persistent infection specializes H. pylori both for individual
variation in mucosal glycosylation and tropism for local areas of inflamed and/or dysplastic tissue.
Citation: Aspholm M, Olfat FO, Norde ´n J, Sonde ´n B, Lundberg C, et al. (2006) SabA is the H. pylori hemagglutinin and is polymorphic in binding to sialylated glycans. PLoS
Pathog 2(10): e110. DOI: 10.1371/journal.ppat.0020110
Introduction
The gastric pathogen Helicobacter pylori exhibits speciﬁc
tropism for gastric mucosa in human populations worldwide
[1]. Adherence to gastric epithelium may beneﬁt the
bacterium by placing it in close contact with epithelial
surfaces and nutrients leaching from host cells that are
damaged by local inﬂammation processes. The size of the H.
pylori genome is only one-third of that of Escherichia coli, with
ensuing limitations in metabolic pathways [2] and adoption of
an adhesive and intracellular parasitic lifestyle. In addition,
binding to highly glycosylated mucins in the mucus layer
closest to the epithelium may stabilize H. pylori colonization
and thus avoid clearance of infection caused by high
epithelial turnover and shedding of the mucus layer [3]. H.
pylori has been shown to adhere to erythrocytes and
neutrophils in vitro [4,5], and virulence-associated cag
þ H.
pylori strains have been shown to invade both the gastric
mucosa and individual cells [6–10]. Thus, the ability to adhere
may also affect the outcome of H. pylori infection by
facilitating focused delivery of effector molecules into the
host cell [11,12]. Consequently, during infection, tissue
invasion and migration of H. pylori bacterial cells through
the endothelial lining of capillaries and post-capillary venules
followed by adherence to blood cells may result in transfer
and systemic dissemination of H. pylori.
H. pylori adapts to the gastric environment by binding to
oligosaccharides (glycans) of various complexities, so-called
receptors or binding epitopes for establishment of infection
in different parts of the mucosa. These glycans are presented
on cell surfaces by glycoproteins and glycosphingolipids, and
in the gastric mucus by MUC5AC and MUC6 mucin molecules
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blood group antigens [14], glycans with charged modiﬁcations
such as sialic acid [15] and sulfate [16], and, in addition,
unsubstituted core chain glycans [17]. The many different
receptor structures described for mucosal adherence suggest
that, similar to multiadhesive pathogens such as Pseudomonas
aeruginosa, H. pylori expresses a range of different attachment
proteins, so-called adhesins [18]. The best-characterized
interaction between H. pylori adhesins and host cell receptors
is that between the blood group antigen–binding adhesin
(BabA) and the ABO blood group and Lewis b (Leb) antigens
[14]. ABO/Leb blood group antigens are best known from
erythrocytes, but they are also highly expressed in the
epithelium and mucus lining in the oro-gastrointestinal tract
[19], where they are known as histo–blood group antigens [20].
As shown in a previous study, a H. pylori babA deletion
mutant that cannot bind ABO/Leb blood group antigens
nevertheless binds to gastric epithelium [15]. Further analysis
showed that the babA mutant preferentially bound to
inﬂamed gastric mucosa, and that binding was mediated by
sialylated glycans such as sialyl-Lewis x (sLex) and sialyl-Lewis
a (sLea). The sLex and sLea glycans are better known as the
glycan binding sites for the selectin family of cell adhesion
molecules. Expression of selectin molecules is activated by
inﬂammatory responses, and they have important roles in
recruitment of white blood cells from circulation to the tissue
in need (reviewed in [21]). Infection of the gastric mucosa by
H. pylori results in inﬂammatory responses, with concomitant
expression of sialylated glycans. H. pylori has been suggested
to exploit mechanisms of ‘‘selectin mimicry’’ to ‘‘home in’’ on
inﬂamed gastric tissue by binding to epithelial sLex and sLea.
By analysis of both gastric biopsy material from individuals
with gastritis or peptic ulcer disease and experimentally
infected Rhesus monkeys, strong correlations were found
between expression of sialylated Lewis antigens, gastritis, and
H. pylori infection. Similar to BabA, the sialic acid–binding
adhesin, SabA, was puriﬁed and identiﬁed by the retagging
technique based on its afﬁnity for sLex [15].
Sialylated glycoconjugates are common binding sites for
both Gram-negative and Gram-positive bacteria [22], inﬂu-
enza and adenoviruses [23,24], and parasites [25]. Hemag-
glutination analysis is an established method for
characterization of microbial adherence to host cell surfaces.
Analysis of sialic acid–dependent hemagglutination (sia-HA)
has been facilitated by the easy removal of sialylated epitopes
by sialidase enzyme, and has been reﬁned in some cases by
complementary enzymatic resialylation of cell surfaces
[22,26]. Soon after its discovery, H. pylori was shown to
agglutinate erythrocytes [4]. The activity was suggested to be
dependent on sialic acid since the HA activity was lost by
prior sialidase treatment of erythrocytes [27]. About one-
third of fresh clinical H. pylori isolates demonstrate sialidase-
sensitive HA [28]. This ﬁgure is similar to the prevalence of
sLex binding among clinical isolates [15]. The sialic acid–
binding epitope was characterized as NeuAca2–3Gal since
sialyl-lactose could competitively inhibit sia-HA [27]. The N-
acetyl-neuraminyl-lactose–binding hemagglutinin was origi-
nally afﬁnity puriﬁed by use of a sialylated serum protein and
denoted H. pylori adhesin A (HpaA) [29]. However, results
from later studies have questioned the role of HpaA in sia-
HA; ﬁrst, a hpaA deletion mutant demonstrated no reduction
in sia-HA activity; [30] and second, immunogold localization
analysis suggested that HpaA is most likely a ﬂagellar sheath
protein [31]. Similarly, the H. pylori neutrophil-activating
protein (HP-NAP) has been described to exhibit sialic acid–
binding properties [32]. However, a J99 HP-NAP depleted
mutant was no different from the parent strain in sialic acid–
binding or in sia-HA properties [33].
Here we report that H. pylori can be found on erythrocytes
in capillaries and post-capillary venules in gastric mucosa of
infected humans and Rhesus monkeys. These results extend
our earlier ﬁndings that H. pylori is a facultative intracellular
bacterium that can leach from the lumen of the stomach into
epithelial cells and the lamina propria [9], indicating that the
bacterium may disseminate into the circulation by way of
gastric mucosal capillaries. Our results also demonstrate that
the SabA adhesin is the sought-after sialyl-dependent
hemagglutinin of H. pylori. The preferred binding sites for
SabA on the erythrocyte cell surface were mapped to
extended ganglioside glycans. We also found a high level of
polymorphism in sialyl-binding properties among clinical
isolates, which suggest functional adaptation of SabA both to
individual and disease-related differences in mucosal sialyla-
tion patterns.
Results
Adherence of H. pylori to Erythrocytes in Capillaries and
Post-Capillary Venules in Gastric Mucosa of Infected
Humans and Rhesus Monkeys
Rhesus monkeys and humans have very similar gastric
anatomy, histology, and mucosal glycosylation patterns, and
they can be naturally infected by H. pylori. In addition, H.
pylori infection is associated with mucosal inﬂammation,
gastritis [6], and sialylated mucosal glycosylation pattern [15].
Biopsies harvested from the gastric mucosa of humans and
experimentally infected Rhesus monkeys were analyzed for
spatial localization of H. pylori cells. Genta-stained and
toluidine blue–stained sections of gastric mucosa (Figure 1A
and 1B, respectively) revealed the presence of a few H. pylori
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Synopsis
Helicobacter pylori infections are very common worldwide and cause
chronic inflammation in the stomach (gastritis), which may progress
to peptic ulcer disease and stomach cancer. In the gastric
epithelium, H. pylori infections induce expression of inflammation-
associated ‘‘sialylated’’ carbohydrates. The ability to bind to the
glycosylated epithelial cells is considered to be essential for H. pylori
to cause persistent infection and disease. Here the authors show
that during established infection, H. pylori also binds to red blood
cells in gastric mucosal blood vessels in both infected humans and
Rhesus monkeys. The authors found that ‘‘sialic acid–binding
adhesin’’ (SabA), is the bacterial surface protein that mediates
binding of H. pylori to red blood cells. Furthermore, they show that
clinical H. pylori isolates demonstrate ‘‘polymorphism’’ in their
abilities to bind various sialylated carbohydrates, and that the
variation in binding properties depends on the sialic acid–binding
adhesin protein itself. This variability may adapt the binding
properties of H. pylori both to individual hosts and the changing
epithelial glycosylation patterns during chronic inflammation.
Continuous adaptation to inflamed tissue during persistent infec-
tions is probably a general feature of microbial pathogens, although
their binding properties have not yet been explored in detail.bacterial cells tightly associated with erythrocytes within
capillaries and post-capillary venules in addition to the
previously reported distribution of the bacterial cells in the
lumen and foveolar epithelium [9]. To test if these bacterial
cells were H. pylori that had invaded the gastric tissue of
Rhesus monkeys and entered the microcirculation, in situ
hybridization was performed. Thus, bacterial cells attached to
the erythrocyte surfaces were identiﬁed by use of probes
speciﬁc for H. pylori 16S RNA (Figure 1C). Next, the possibility
that H. pylori can also invade blood vessels and adhere to
erythrocytes in humans was analyzed. In situ hybridization in
biopsies of infected human gastric mucosa revealed a similar
localization of H. pylori bacterial cells (Figure 1D). These
results suggest that H. pylori can reach the gastric mucosa
capillaries, attach to erythrocytes, and perhaps disseminate
throughout the body of both humans and Rhesus monkeys.
Importantly, the number of bacterial cells in the endothelial
lining was drastically lower compared to the foveolar
epithelium (illustrated in Figure 1A). This difference in H.
pylori bacterial cell density is consistent with the absence of
clinical cases with overt sepsis caused by H. pylori infection.
Correlation between sia-HA and sLex Binding
A series of 99 Swedish clinical H. pylori isolates were tested
for both sia-HA and for binding to sLex glycoconjugate. Sia-
HA was assessed by desialylation of human erythrocytes with
sialidase from Clostridium perfringens, a glycosidase that
hydrolyses a2–3–, a2–6–, and a2–8–linked sialic acid in
oligosaccharide chains of natural glycoconjugates, such as
glycoproteins and glycosphingolipids. Enzymatic desialyla-
tion of the erythrocyte surfaces and subsequent removal of
sialylated bacterial binding sites would result in reduced
erythrocyte aggregation, and thus reduced HA titers. For the
series of clinical isolates, sialidase-dependent shifts in HA
titers ranged from  2t o  2, where positive values relate to
the expected effect of sialidase on HA (i.e., the reduction in
sialyl-dependent binding by one to three titer shifts).
Negative values correspond to strains that, in contrast,
increase HA titers due to removal of sialic acid (i.e., sialyl-
independent HA). HA titers (1 to   2) were found for 27
isolates (27%), whereas 31 isolates (31%) showed increased
HA titers ( 1t o 2). The remaining 41 isolates (41%)
displayed no change in sia-HA titers (Figure 2A).
Figure 1. H. pylori Adheres to Erythrocytes in Capillaries and Post-Capillary Venules of Infected Humans and Rhesus Monkeys
(A) Genta-stained section of human gastric biopsy. Black spiral- and comma-shaped bacteria are observed in the lumen of the stomach, adherent to
gastric epithelial cells, within the mucus globule of the cells. Bacterial cells (arrow) are also present in close contact to an erythrocyte within a capillary
located in the supporting connective tissue of lamina propria of the mucosa.
(B) Section of human gastric biopsy stained with toluidine blue. A capillary vessel lined by endothelial cells is visible in the lamina propria of the mucosa.
It contains several erythrocytes to which H. pylori are attached. Insert: higher magnification of two H. pylori (arrows) in close approximation to
erythrocytes.
(C) Section of a Rhesus monkey gastric biopsy. In situ hybridization was performed using probes specific for H. pylori 16S rRNA, demonstrating the
presence of several H. pylori apparently attached to erythrocyte surfaces of a post-capillary venule located in the lamina propria of submucosa. Inserts:
higher magnification of H. pylori bacterial cells (arrows) in close approximation to erythrocytes.
(D) Section of a human gastric biopsy. In situ hybridization was performed using probes specific for H. pylori 16S rRNA. This high magnification of a
capillary immediately adjacent to a gastric gland (on the top-right corner of the picture) demonstrates the presence of several H. pylori bacterial cells,
stained blue, apparently attached to the surfaces of erythrocytes.
Bars ¼ 5 lm.
DOI: 10.1371/journal.ppat.0020110.g001
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Polymorphism in H. pylori Sialyl Binding AdhesinFor the series of 99 clinical isolates, HA titers were
compared with prevalence of sLex binding. This was assessed
by the use of
125I-labeled sialyl-dimeric Lex (sdiLex) antigen
conjugate. The sdiLex antigen consists of two repetitive and
fucosylated Lex antigens terminally substituted with a2–3–
linked sialic acid (Table 1). A total of 37 of 99 isolates (37%)
could bind to sdiLex, and 22 of 37 (60%) of these isolates
proﬁcient in sdiLex binding also demonstrated reduction in
sialyl-dependent binding (sia-HA properties). In comparison,
among the 62 isolates that did not bind sdiLex, only ﬁve
isolates (8%) demonstrated sia-HA properties. In the group
of 31 isolates that instead increased their HA titers due to
sialidase treatment, only one single isolate showed distinct
sdiLex binding, two isolates bound weakly, and the great
majority (28 isolates) completely lacked sdiLex-binding
properties (Figure 2A).
A strong correlation was found between bacterial binding
to sdiLex and HA titers resulting from sialidase treatment
(correlation of rank ¼ 0.547; p , 0.001) (Figure 2A). These
results demonstrate that clinical isolates that are reduced in
HA activity due to desialylation of erythrocytes by sialidase
treatment constitute the group of H. pylori strains in which
the great majority can bind sialylated Lewis antigens.
A sabA Deletion Mutant Identified SabA as the Sialyl-
Dependent Hemagglutinin
Strain J99 has previously been shown to express the SabA
adhesin and to bind sialylated Lewis glycans such as sdiLex,
sLex, and sLea (Table 1). By comparison, the J99 sabA deletion
mutant (J99sabA) has lost the ability to bind sialyl-Lewis
antigens [15]. Here, the J99 and J99sabA strains were
compared for sia-HA properties. The results showed that
while strain J99 was positive for sia-HA, the J99sabA mutant is
fully devoid of all sia-HA properties (Table 2, 163[a] versus 0
[b]). This result is most consistent with SabA being the sialyl-
dependent hemagglutinin of H. pylori. In comparison, the J99
Figure 2. Characterization of Binding Properties of the SabA Adhesin, and Its siaHA Properties
(A) A panel of 99 Swedish clinical H. pylori isolates was tested for sia-HA properties and for binding to
125I-sdiLex conjugate. The numbers on the x axis
indicate the shifts in HA titers after sialidase treatment: positive values indicate lowered sia-HA titers (i.e., sia-HA, whereas negative values indicate
increased HA titers (i.e., sialic acid–independent HA). No change in HA titer is indicated by 0. The y axis gives the percentage of bound sLex-conjugate.
(B) SabA was affinity-adsorbed to erythrocytes from a cell-surface protein extract of strain J99. Immunostaining using SabA antibodies confirmed the
presence of SabA adsorbed onto the erythrocyte surfaces as a result of binding to sialylated glycans (lane 1), whereas SabA was completely absent
when erythrocytes had been depleted of sialic acid by sialidase treatment prior to the test (lane 2). Molecular weight markers (in kDa) are indicated.
(C) Binding of H. pylori strains J99 and J99sabA to human erythrocyte glycosphingolipids. (i) Chemical detection by anisaldehyde. (ii–iii) Autoradiograms
obtained by binding of
35S-labeled H. pylori strain J99 and the J99sabA mutant, respectively, to separated glycosphingolipids. The lanes contain non-
acid glycosphingolipids of human erythrocytes, 40 lg (lane 1); gangliosides of human erythrocytes, 40 lg (lane 2); GM3 ganglioside (NeuAca2–
3Galb4Glcb1Cer), 4 lg (lane 3); NeuAca2–3-neolactotetraocylceramide
(NeuAca2–3Galb4GlcNAcb3Galb4Glcb1Cer), 4 lg (lane 4); NeuAca2–6-neolactotetraocylceramide
(NeuAca2–6Galb4GlcNAcb3Galb4Glcb1Cer), 4 lg (lane 5); G-10 ganglioside (NeuAca2–3Galb4GlcNAcb6 (NeuAca2–3Galb4GlcNAcb3)Galb4GlcNAcb3-
Galb4Glcb1Cer), 1 lg (lane 6); G9-B ganglioside (Gala3(Fuca2)Galb4GlcNAcb6
(NeuAca2–3Galb4GlcNAcb3)Galb4GlcNAcb3Galb4Glcb1Cer), 1 lg (lane 7); and reference gangliotriaosylceramide (GalNAcb4Galb4Glcb1Cer) of mouse
feces, 4 lg (lane 8).
DOI: 10.1371/journal.ppat.0020110.g002
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Polymorphism in H. pylori Sialyl Binding AdhesinbabA deletion mutant (J99babA) was not affected in sia-HA,
but instead behaved most similarly to the J99 parent strain
(Table 2, 16x [c] versus [a]). Taken together, the results also
demonstrate that binding by BabA to fucosylated blood
group antigens does not confer erythrocyte aggregation and
HA.
SabA Is Adsorbed to Sialylated Erythrocyte Surfaces
Binding of solubilized SabA protein was analyzed by
afﬁnity adsorption to sialylated erythrocyte surfaces. Here,
a cell-surface protein extract from strain J99 was mixed with
naive or sialidase-treated erythrocytes. Immunoblot analysis
with antibodies against SabA showed that SabA was afﬁnity
absorbed onto intact and sialylated erythrocytes, whereas no
SabA bound to sialidase-treated and sialic acid–depleted
erythrocytes (Figure 2B).
Topographic Mapping of the Sialylated Binding Sites on
Erythrocytes that Confer sia-HA by H. pylori
Sialylated erythrocyte antigens have been described in
glycoproteins such as glycophorin A [22], in glycosphingoli-
pids (gangliosides), and in polyglycosylceramides [34]. Sialy-
lated bacterial binding sites were topographically localized on
erythrocytes by functional discrimination between sialylated
glycoproteins, which reach above the membrane level, and
tight membrane–associated gangliosides. Erythrocytes were
ﬁrst treated with protease (trypsin) to destroy most glyco-
proteins at the erythrocyte surface, followed by treatment
with sialidase to test for sialic acid–dependent binding sites.
Proteolytic removal of cell-surface glycoproteins resulted in a
distinct increase in sia-HA for both the J99 wt strain and the
J99 babA mutant (Table 2, [d] and [e]). In contrast, S-
ﬁmbriated E. coli, which is known to hemagglutinate by
binding to the sialylated erythrocyte glycoprotein glycophor-
in A (Table 2, [1]) [22], was most sensitive to protease
treatment of erythrocytes, which even at low concentrations
completely abrogated sia-HA (Table 2, [f] versus [g]). Similar
to H. pylori, protease treatment of erythrocytes conferred
stronger HA of P-ﬁmbriated E. coli, which binds Gala4Gal
antigens that are only present in glycolipids. This is most
likely due to increased accessibility of the adhesive P-ﬁmbriae
for the Gala4Gal receptor epitopes present in membrane-
close glycolipids (Table 2, [h] versus [i]). In addition, sialidase
treatment and removal of the charged sialic acid residues
could confer better exposure of the Gala4Gal receptor
epitopes in glycan core chains and increased sia-HA (Table
2, [j] and [k] versus [h]). Taken together, the results show that
the main part of sia-HA is conferred by sialyl-dependent
binding of SabA to the tight membrane–associated and
sialylated glycosphingolipids (i.e., gangliosides).
SabA Binds to Gangliosides from Human Erythrocytes
The major ganglioside structures found in human eryth-
rocytes are the GM3 ganglioside and NeuAca2–3-neolactote-
traosylceramide (Table 3; NeuAca3SPG). In addition, a
number of minor complex gangliosides have been described
[35]. Binding of strain J99 to non-acid and sialylated
glycosphingolipid fractions of human erythrocytes immobi-
lized on thin-layer chromatography plates (i.e., solid phase
presentation) was analyzed (Figure 2Cii, lanes 1 and 2,
respectively). The NeuAca2–3-neolactotetraosylceramide re-
gion of the acid fraction (lane 2) was positive for binding,
while no binding by strain J99 to the non-acid glycosphingo-
lipids was observed. A higher sensitivity was obtained when
puriﬁed human erythrocyte gangliosides was used (lanes 3–7).
As for the acid glycosphingolipid fraction (lane 2), strain J99
bound to puriﬁed NeuAca2–3-neolactotetraosylceramide
(lane 4). In addition, the bacteria bound the puriﬁed complex
gangliosides G-10 and G9-B (lanes 6 and 7). These structures
are minor components of the erythrocyte gangliosides, which
may explain their lack of binding in the crude fraction (lane
2). Strain J99 did not bind the shorter GM3 ganglioside (lane
3), nor did it bind the a2–6–linked NeuAca2–6-neolactote-
traosylceramide (lane 5 and Table 3; NeuAca6SPG). Interest-
ingly, NeuAca2–8 modiﬁcations to the NeuAca2–6–
Table 2. Bacterial HA of Enzyme-Treated Erythrocytes
RBC Treatment Dilution of Bacterial Cells
J99 J99sabA J99babA E. coli
P-fim
E. coli
S-fim
0 mg Tryp þ 0 U Sia 163 (a)   (b) 163 (c) 23 (h) 43 (f)
0 mg Tryp þ 0.1 U Sia      83 (j)   (l)
0.05 mg Tryp þ 0U Sia 323 (d)   323 (e) 83 (i)   (g)
0.05 mg Trypþ 0.1U Sia      163 (k)  
H. pylori strain J99 and the J99sabA and J99babA mutants were examined for HA of
erythrocytes treated with different concentrations of trypsin (Tryp) and/or sialidase (Sia).
As controls, P-fimbriated (P-fim) and S-fimbriated (S-fim) E. coli strains were analyzed for
HA properties. The ‘‘Dilution of Bacterial Cells’’ (2x–32x) refers to the maximum bacterial
dilution in which HA could be detected, and ( ) indicates lack of HA. The letters (a–l)
within parentheses are explained in the Results section ‘‘Topographic Mapping of the
Sialylated Binding Sites on Erythrocytes that Confer sia-HA by H. pylori.’’
DOI: 10.1371/journal.ppat.0020110.t002
Table 1. Soluble Glycoconjugates Used in This Study
Oligosaccharides Structures
Leb Fuca2Galb3(Fuca4)GlcNAcb3Galb4(Glc)-APD-HSA
sdiLex NeuAca2–3Galb4(Fuca3)GlcNAcb3Galb4(Fuca3)GlcNAcb3Galb4(Glc)-APD-HSA
sLex NeuAca2–3Galb4(Fuca3)GlcNAcb3Galb4(Glc)-APD-HSA
sLea NeuAca2–3Galb3(Fuca4)GlcNAcb3Galb4(Glc)-APD-HSA
39-sialyl-lactose NeuAca2–3Galb4(Glc)-APD-HSA
69-sialyl-lactose NeuAca2–6Galb4(Glc)-APD-HSA
sLn(3) NeuAca2–3Galb4GlcNAc-3 atom spacer-BSA
sLn(14) NeuAca2–3Galb4GlcNAc-14 atom spacer-BSA
DOI: 10.1371/journal.ppat.0020110.t001
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Polymorphism in H. pylori Sialyl Binding Adhesinsubstituted GD3 and DPG glycans seemingly interfered with
SabA-mediated binding. Similarly, the GD1a glycan, which is
similar to the NeuAca2–3-neolactotetraosylceramide (Neu-
Aca3SPG), but with an additional NeuAca2–3 residue linked
to the core, had lost its binding epitope for SabA (Table 3),
which further points to the importance of the steric
presentation of the NeuAca2–3Gal epitope for the SabA-
mediated binding mode. The absolute requirement for SabA
was demonstrated by the sabA deletion mutant strain J99sabA,
which did not bind to any of the gangliosides tested (Figure
2Ciii), although there was consistent SabA-independent
binding to the reference non-acid gangliotriaosylceramide
(lane 8; [36]).
Characterization of H. pylori Binding Specificities to
Sialylated Glycans
The sialylated receptor epitope for SabA was further
characterized by use of structurally deﬁned sialylated
glycoconjugates of various complexities in terms of fucosy-
lation and core chain and spacer unit lengths (Figure 3). The
extended sdiLex antigen was recently shown to be the best
receptor for SabA, which further suggests that fucosylation,
sialylation, and length of the core chain are parameters that
together form a high-afﬁnity binding epitope for SabA.
NeuAca2–3-lactose and NeuAca2–6-lactose were ﬁrst com-
pared for bacterial binding. Both structures are based on
puriﬁed sialyl-lactose structures, but the glucose ring has
been opened by reductive amination and used for conjuga-
tion to albumin, which leaves only the NeuAc-Gal disacchar-
ide intact and available for bacterial binding. Strains J99,
CCUG17875 (17875), 17875babA1A2, CCUG17874 (17874),
SMI65, and SMI27 all bound the NeuAca2–3-lactose con-
jugate, while none of the strains tested bound the NeuAca2–
6-lactose conjugate. The results suggest that presentation of
the sialic acid residue by the a2–3 linkage is essential for
Figure 3. Binding of H. pylori Strains and Clinical Isolates to Fucosylated and Sialylated Glycans of Various Complexities
H. pylori reference strains, mutants, and clinical isolates were tested for binding to the fucosylated Leb antigen and to a series of sialylated antigens, all
presented by
125I-labeled albumin conjugates. The y axis gives the percentage of bound conjugate.
DOI: 10.1371/journal.ppat.0020110.g003
Table 3. Results from Binding of H. pylori to Human Erythrocyte Gangliosides
Gangliosides Trivial Names Structures Binding
Monosialo-gangliosides G1 NeuAc-GM3 NeuAca2–3Galb4Glcb1Cer  
G2 NeuAca3SPG NeuAca2–3Galb4GlcNAcb3Galb4Glcb1Cer þ
G4 NeuAca6SPG NeuAca2–6Galb4GlcNAcb3Galb4Glcb1Cer  
G6 NeuAca3-nLc6 NeuAca2–3Galb4GlcNAcb3Galb4GlcNAcb3Galb4Glcb1Cer þþþ
G9-B Gala3(Fuca2)Galb4GlcNAcb6(NeuAca2–3Galb4Glc-
NAcb3)Galb4GlcNAcb3Galb4Glcb1Cer
þþþ
Di-sialo-gangliosides GD3 NeuAca2–8NeuAca2–3Galb4Glcb1Cer  
DG3 DPG NeuAca2–8NeuAca2–3Galb4GlcNAcb3Galb4Glcb1Cer  
G-10/DG6 NeuAca2–3Galb4GlcNAcb6(NeuAca2–3Galb4Glc-
NAcb3)Galb4GlcNAcb3Galb4Glcb1Cer
þþþ
GD1a NeuAca2–3Galb3GalNAcb4(NeuAca2–3)Galb4Glcb1Cer  
GD1b Galb3GalNAcb4(NeuAca2–8NeuAca2–3)Galb4Glcb1Cer  
Binding of strain J99 is defined as follows:þþþ denotes binding when less than 0.5 lg of the glycosphingolipid was applied on the thin-layer chromatogram, whileþdenotes occasional
binding at 0.5 lg, and   denotes no binding even at 4 lg.
The glycosphingolipid nomenclature follows the recommendations by the International Union of Pure and Applied Chemistry–International Union of Biochemistry (IUPAC-IUB)
Commission on Biochemical Nomenclature.
It is assumed that Gal, Glc, GlcNAc, GalNAc, and NeuAc are of the D-configuration, Fuc is of the L-configuration, and that all sugars are present in the pyranose form.
DOI: 10.1371/journal.ppat.0020110.t003
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for binding to gangliosides in solid phase. Since binding by
SabA to sialyl-lactose was rather weak for all strains, the
inﬂuence of chain length and steric ﬂexibility in promotion
of binding was investigated by use of sialyl-lactosamine (sLn;
NeuAca3Galb4GlcNAc) attached to albumin, by either the
short three-atom [sLn(3)] or the extended 14-atom [sLn(14)]
spacer molecules. All strains that bind to sialylated glycans
bound  4-fold better to sLn(14) than to sLn(3). Strains J99,
SMI65, and SMI27 bound strongly to both sLea and sLex,
whereas strains 17875, 17874, and the 17875babA1A2 mutant
demonstrated much weaker binding to sLea compared to
sLex/sdiLex. In keeping with our previous results, strains
26695, J99sabA, and 17875/Leb (a spontaneous mutant which
does not bind sialylated antigens) appear to lack binding
properties for sLex/sdiLex, sLea [15], and for the sialyl-
lactose/lactosamine conjugates tested here.
Analysis of Binding Affinities for Sialylated Antigens
The binding afﬁnities of strains J99, 17874, SMI65, SMI27,
and the mutant 17875babA1A2 for the series of sialylated
conjugates described above were analyzed according to
Scatchard [37] (Figure 4). Strains J99, SMI65, and SMI27
demonstrated similar proﬁles in binding afﬁnities for the
series of sdiLex, sLex, sLea, and sLn(14) in the range of 9.6 3
10
8 M
 1 to 6.4 3 10
9 M
 1. By analogy with the results above,
all three strains demonstrated lower binding afﬁnity for
sialyl-lactose (5.1 3 10
8 M
 1 to 6.1 3 10
8 M
 1). However, sialyl
binding is not uniform among strains, since strains 17874 and
17875babA1A2 demonstrated a different binding pattern,
with 10-fold lower afﬁnity for sLea (9.7 3 10
7 M
 1 and 1.0 3
10
8 M
 1, respectively) and reduced afﬁnity for sialyl-lactose
(2.0310
8 M
 1 and 1.9310
8 M
 1, respectively). In the present
experimental series, the 17875babA1A2 mutant exhibited
binding afﬁnities, which are approximately 10-fold higher
than previously reported [15]. The stronger binding afﬁnity
reported relates to the improved bovine serum albumin
(BSA) preparation used here as blocking agent, because we
found BSA to contain sialyl-competitive constituents (un-
published data). Interestingly, binding to nonsialylated
glycans such as Leb was not affected by the improved BSA
preparation, which might be due to lack of the human/
primate-speciﬁc antigen, Leb, in bovine serum constituents.
To remove endogenous sialylated glycans, periodate oxida-
tion of the BSA preparation was performed. This treatment
resulted in .10-fold higher binding afﬁnities of H. pylori for
sLex, and consequently, the deglycanated blocking agent was
used for all binding analyses in this study.
Polymorphism in Binding to Sialylated Glycans among
Clinical Isolates
The 99 Swedish clinical isolates were all analyzed for
binding to sdiLex, sLea, and sLn(14) glycans (Figure 5). Of
those, 39 (39%) could bind to sialylated glycans, and the great
majority, 34 (87%) of 39 of these isolates, could bind all three
Figure 4. Binding Affinities Analyzed According to Scatchard of H. pylori
Reference Strains, a babA Deletion Mutant, and Clinical Isolates for
Sialylated Glycans
DOI: 10.1371/journal.ppat.0020110.g004
Figure 5. Different Sialyl-Dependent Binding Modes of H. pylori
Identified by Use of sdiLex, sLea, and sLn Conjugates
A total of 39 Swedish clinical isolates were investigated for detailed sialyl-
dependent binding properties. Representatives of the different binding
modes for
125I-labeled sialylated glycans are illustrated in the diagram: (i)
(in thick line) binds efficiently to all three sialylated glycans with
preferential binding to sdiLex; (ii) binds to all three sialylated glycans,
with better binding to sLea (‘‘K-shaped’’ hatched line); (iii) binds
preferentially to sdiLex and sLn(14) (‘‘V-shaped’’ dotted line); (iv) binds
preferentially to sdiLex but exhibits only modest binding for sLea and
sLn(14) sialyl conjugates; and (v) binds modestly for all sialyl conjugates
(,5% bound conjugate). The y axis gives the percentage of bound
conjugate.
DOI: 10.1371/journal.ppat.0020110.g005
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isolates only bound sLea, but isolates with such unusual
binding properties were generally poor binders (,1.5% of
bound conjugate). Multiple different sialic acid–dependent
adherence modes were found among the 39 sialyl-binding
isolates, and these were classiﬁed as follows: (1) isolates that
bind to all three sialylated glycans, with preferential binding
to sdiLex (12 of 39 isolates, or approximately 30%); (2)
isolates that bind to sLea better than sdiLex and sLn(14) (i.e.,
strains with an ‘‘K-shaped’’ binding mode) (seven of 39
isolates, or approximately 20%); (3) isolates that bind sdiLex
and sLn(14) the best, whereas binding to sLea is lower (i.e.,
isolates with a ‘‘V-shaped’’ binding mode [similar to the
binding mode of strain 17874; Figure 3]) (three of 39 isolates,
or approximately 10%); (4) isolates that bind sLex but show
only modest binding to sLea and sLn(14) (seven of 39 isolates,
or approximately 20%); and (5) isolates generally modest in
binding (in the interval 1%–5%) for all sialyl conjugates (ten
of 39 isolates, or approximately 20%). As shown in Figure 5,
preferential binding to sdiLex was the most common binding
mode among the clinical isolates tested (24 of 39 isolates, or
approximately 60% of strains tested).
Polymorphism in Binding to Sialylated Glycans Is an
Inherent Feature of SabA
To test if SabA alone accounts for the polymorphic binding
modes to sialylated glycans, sabA was deleted in ﬁve clinical
isolates, which together are representative of the main modes
of sialyl-dependent binding (as analyzed in Figure 5). All ﬁve
isogenic sabA deletion mutants were tested both for binding
to
125I-labeled sdiLex, sLea, and sLn glycan conjugates and for
expression of SabA. The results showed that the series of sabA
deletion mutants could no longer bind to sialylated antigens,
which suggests that SabA is the main factor responsible for
polymorphism in binding to sialylated antigens (Figure 6). To
thoroughly investigate if the local environment, such as the
outer membrane and lipopolysaccharide composition of the
individual strain, could inﬂuence sialyl-dependent binding
properties of SabA, a complementation test was performed.
The test was based on the Swedish clinical isolate SMI9 and
the reference strain J99, which exhibits low and high
proﬁciency in binding to sLea, respectively, whereas both
strains bind sdiLex and sLn the most similarly (Figure 6). The
deletion mutant SMI9sabA::kan, which cannot bind to
sialylated antigens, was used as a background strain for
complementation with the sabA open reading frame of strain
J99. Transformant clones with gained sialyl antigen–binding
properties were isolated by an enrichment procedure based
on HA and identiﬁed by colony screening using SabA
antibodies. SabA-positive transformants were analyzed for
binding to sdiLex, sLea, and sLn(14) glycans, and the
SMI9sabAJ99 complementation mutant was identiﬁed. The
donor strain J99 exhibits the high sLea/sdiLex binding afﬁnity
ratio of 1.1, whereas the recipient strain SMI9 exhibits the low
sLea/sdiLex ratio of 0.3. Interestingly, the SMI9sabAJ99
complementation mutant demonstrated a sLea/sdiLex bind-
ing afﬁnity ratio of 0.93 (i.e., SabAJ99 expressed in the
background strain SMI9 is most similar in afﬁnity to that of
the donor strain J99) (Figure 7). The sdiLex-binding capacity,
which reﬂects the number of functional SabA adhesins on the
bacterial surface, remained the same (1.2 nM) in strain SMI9
after introduction of the sabAJ99 gene. In comparison, strain
J99 exhibits a binding capacity of 0.5 nM for sdiLex. Sequence
analyses demonstrated that full-length J99 sabA had recom-
bined into the sabA locus of SMI9 sabA::kan and formed a
Figure 6. Analyses of SabA-Dependent Binding among Clinical Isolates
(A) Binding characteristics of H. pylori clinical isolates and SabA-deficient
isogenic mutants were studied by use of soluble
125I-labeled sdiLex, sLea,
and sLn(14) conjugates.
(B) Immunoblot analysis of H. pylori clinical isolates and mutant strains
using SabA antibodies. There were no SabA bands detected among the
sabA deletion mutants; actually, there were no additional bands on the
blots.
DOI: 10.1371/journal.ppat.0020110.g006
Figure 7. Analyses of Binding Affinities for Sialylated Antigens by SabA
from Strain J99 Complementarily Expressed in Background Clinical Strain
SMI9
Binding affinities of H. pylori strains J99, SMI9, and the complementation
mutant SMI9sabAJ99 were analyzed according to Scatchard. Binding
affinities and the percentage ratio of sLex/sLea binding affinities are
indicated.
DOI: 10.1371/journal.ppat.0020110.g007
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sdiLex binding ratio depends exclusively on the sabAJ99
complementation, a SMI9sabAJ99::cam deletion mutant was
made. Immunoblot and binding analyses of the SMI9sabAJ99::-
cam mutant demonstrated both absence of SabA expression
and sialic acid binding properties (unpublished data). Taken
together, these results conclude that the sialyl polymorphism
binding is an inherent characteristic of the SabA adhesin
protein itself.
Discussion
Epithelial adherence should beneﬁt H. pylori by providing
better access to nutrient-rich tissues, and may contribute to
delivery of bacterial toxins and various effector molecules
through the type IV secretion mechanisms. Tight adherence
may also be deleterious for H. pylori whenever robust host
responses confront the bacterium with bactericidal agents.
This suggests that persistence of H. pylori in the gastric
mucosa depends on the maintenance of a balanced mode of
mucosal adherence and the continuous adaptation of its
binding properties to functionally match shifts in host
glycosylation patterns during chronic inﬂammation. Mecha-
nisms of rapid adaptation to local inﬂammation responses
may be conferred by rapid on/off phase variation in SabA
expression [15] and recombination events involving babA and
babB [38,39].
Once established in the gastric epithelium, H. pylori tends to
invade the gastric mucosa by slippage through the tight-cell
junctions, which is a process that requires reorganization of
the cytoskeleton and induced cell morphology [7]. Within the
gastric tissue there are several alternative routes available for
H. pylori, such as SabA-mediated adherence to neutrophils
that have invaded the gastric mucosa [5]. Alternatively, H.
pylori can enter into an intracellular lifestyle, and can invade
gastric epithelia cells, whether normal, metaplastic, dys-
plastic, or cancerous [9], and possibly also gastric stem cells
[10]. The inﬂammatory processes also confers upregulation of
sialylated and sulfated carbohydrates in the local vessel lining
(i.e., addressins), which act to ‘‘home in’’ on neutrophils from
the peripheral circulation (i.e., recruits and activates the
inﬂammatory cells from circulation and directs them to local
areas of inﬂamed and infected tissue [40]). The sialylated
parts of the addressins are most similar to the sialylated
glycans that are bound by SabA. Thus, invasion of the high-
endothelial venule–like vessels might be mediated by SabA-
dependent adherence, ﬁrst to the endothelial lining, and later
also to the sialylated erythrocytes. In such a putative scenario,
the results presented here are intriguing since systemic
dissemination of microbial pathogens might be related to
systemic disease. Indeed, chronic dental gum infections, such
as periodontal infection in dental pockets, have been shown
to frequently leach bacterial cells into circulation, although
most bacterial cells are quickly killed by the acquired
immunity and complement systems. However, persistent
periodontal disease is associated with arteriosclerosis of the
carotid arteries and coronary heart disease [41,42]. Interest-
ingly, H. pylori infection is also associated with coronary heart
disease, suggesting the inﬂuence of the disseminated bacterial
cells in the long-term development of this pathology [43].
Although the erythrocyte-binding sia-HA phenotype is
prevalent among clinical isolates, it has not yet been
recognized as a virulence property of H. pylori, since sia-HA
has not explicitly been shown to correlate with gastric disease
[28,44]. However, the prevalence of sialic acid binding may
have been underestimated among clinical isolates since: (1) H.
pylori exhibits on/off phase variation in sialyl binding, and sia-
HA could be rapidly lost during passage in culture [15]; (2)
almost half of the strains that bound sLex did not cause sia-
HA (Figure 2), which suggests that many strains require
complex sialylated glycans for binding (such structures are
limited on erythrocytes, but are present both in gastric
epithelium and on neutrophils [45]); and (3) culture con-
ditions have been shown to inﬂuence binding speciﬁcity and
afﬁnity for sialylated glycoconjugates [34]. In this report, we
show that clinical isolates exhibit three distinct HA patterns
in response to sialidase treatment (Figure 2): (1) reduced HA
titers; (2) increased HA titers; or (3) unaltered HA titers.
Reduced HA titers would be the expected effect of sialidase-
dependent depletion of sialic acid, whereas an increase in HA
titers suggests that depletion of sialic acid may better expose
(cryptic) binding sites (i.e., less-accessible glycan epitopes).
The third pattern, with no change in HA titers, probably
relates to combinations of reduced and increased titers (i.e.,
strains with yet additional adhesins. The HA properties were
found to be highly correlated with sLex binding activity,
which implicates SabA as the causative agent in sia-HA. Thus,
by the use of deletion mutants, we were able to unambigu-
ously identify SabA as the H. pylori sialic acid–dependent
hemagglutinin.
To further our understanding of SabA binding, H. pylori
strains and mutants were tested for binding to sialylated
glycans of various lengths and complexities. The results
suggest that the NeuAca2–3Gal disaccharide constitutes the
minimal binding epitope for SabA binding, which is in
agreement with previous reports on the binding speciﬁcity
for the H. pylori sialyl-dependent hemagglutinin [27]. How-
ever, the core chain length was shown to affect SabA-
mediated binding to erythrocyte gangliosides, where the
NeuAca2–3-neolactooctaocylceramide bound much better
than the shorter NeuAca2–3-neolactotetraocylceramide. Sim-
ilarly, semisynthetic glycoconjugates with sialylated glycans
presented on 14-atom spacers bound better than short three-
atom spacers, which suggests that the sialylated binding
epitope is best presented by extended and ﬂexible core
chains. Furthermore, all strains demonstrated increased
binding for sLex, sdiLex, and sLea compared to sialylated
structures lacking fucose constituents. These results are in
keeping with our previous results on high-afﬁnity binding of
SabA to extended gangliosides with repetitive Lex motifs [15].
In the present study, we also showed by protease treatment
analysis of host cell surfaces that H. pylori HA is mainly
mediated by binding to glycosphingolipids. Nevertheless, the
sialylated protein (albumin) conjugates used in this study are
also efﬁcient receptors for SabA-mediated H. pylori binding.
This might in part relate to the uniform coating and
presentation of sialylated glycans on the globular albumin
molecule, which mimic the host cell–surface presentation of
receptor glycans. In addition, the soluble albumin conjugates
are probably more efﬁcient for bacterial binding due to
pretty ﬂexible presentation of the sialylated antigens com-
pared to bacterial binding to surfaces presented glycolipids
(i.e., solid-phase interactions). Thus, strong and multivalent
(‘‘Velcro’’-type) binding to sialylated epitopes on glycosphin-
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promote membrane-tight binding of SabA during experi-
mental HA and in the inﬂamed gastric epithelium.
In the present study, the great majority of sialyl-binding H.
pylori isolates bound the full series of sdiLex, sLea, and sLn
glycans. This is a distinct difference compared to previous
results, where merely half of sLex-binding strains also bound
sLea [15]. The higher prevalence of sLea binders reported
here is probably best explained by the presence of
competitive sialylated antigens in the albumin-based block-
ing agent used previously. This is also supported by the 10-
fold increased binding afﬁnity for sLex, 1310
9 M
 1, revealed
by strain 17875babA1A2 (Figure 4). Interestingly, clinical
isolates demonstrated several distinct binding modes for
sialylated glycans, although most isolates bound best to sLex.
The differences in binding afﬁnities to various sialylated
glycans relate both to complexities in fucosylation and to the
type of lacto-series core chains. Subtle differences in binding
speciﬁcities have been described for urinary tract infectious
Gala4Gal-binding P-ﬁmbriated E. coli. For urinary tract
infectious isolates the length of the globoseries glycolipids,
required for bacterial binding, sorted the cognate adhesins
into different functional subtypes that recognize human or
canine kidney tissue [46,47]. In addition, single amino acid
changes in type-I ﬁmbriated E. coli urinary tract infectious
isolates can change the normal binding mode for antennary
mannosylated structures into a high-afﬁnity binding mode
that also accepts mono-mannosylated structures [48].
Hence, detailed differences in binding properties often
relate to the adhesin polypeptide itself, but the binding mode
can sometimes be distinctly inﬂuenced by physical con-
straints imposed by associated proteins in the local environ-
ment (e.g., the detailed binding speciﬁcity of Salmonella type I
ﬁmbriae is dependent on the ﬁmbrial shaft on which the
FimH adhesin is presented [49]). In contrast to pilus-
associated adhesins, SabA exhibits a C-terminal putative ß-
barrel domain, and hence is most likely instead a membrane-
integrated protein. Our studies point to the fact that the
detailed binding properties of SabA described here, similar to
BabA [14], are inherent features of the adhesin proteins
themselves.
The polymorphic binding to sialylated conjugates probably
relates to small differences in SabA, which is similar to BabA
in that positive selection for nonsynonymous codon sub-
stitutions have generated variant BabA adhesins that dem-
onstrate specialist and generalist binding modes for ABO
blood group antigens [14]. The high mutation rates in H. pylori
[50,51] will promote formation of derivative strains with
modiﬁed binding properties. Polymorphic binding proper-
ties could be of utmost importance during mixed infections,
when recombination and exchange of genetic information
might promote formation of transformants with chimeric
binding properties that together behaves like a quasi-species.
The occurrence of H. pylori strains that express SabA adhesins
with different subtypes of binding modes as described here
could therefore reﬂect such ongoing molecular evolution.
H. pylori infection and gastritis have been found to enhance
gastric mucosal expression of the inﬂammation associated
sLex/sLea antigens [15]. These sialylated glycans are dynam-
ically expressed in competition with fucosylated blood group
antigens [52]. Furthermore, malignant transformation has
been reported to confer a pronounced expression of Lea,
sLea, and sdiLex in the gastric mucosa [19,53]. Such changes
to the differentiation programs of the gastric epithelial cell
lineages will promote expression of a wide range of sialylated
antigens. Taken together, these reports suggest that H. pylori
infection and the associated chronic inﬂammation responses
continuously change the availability of sialylated glycans of
different complexities. Such changes in the gastric sialylation
patterns would select for SabA clones that evolve with new or
modiﬁed binding properties for sialylated epitopes. Thus, the
bacteria–host crosstalk selects for polymorphic clones with
optimal ﬁtness for both the sialyl archipelago of the local
environment (gastric mucosa) and the individual’s phenotype
for balanced, lifelong infection.
Materials and Methods
Bacterial strains. The H. pylori strains used in this study were
CCUG17875, CCUG17874 [54], 26695 [55], J99 [2], the sabA deletion
mutant J99sabA(JHP662)::cam, the babA deletion mutant J99babA::cam,
and the babA ‘‘double’’ mutant 17875babA1::kan babA2::cam (the series
of mutants are abbreviated J99sabA, J99babA, and 17875babA1A2,
respectively). The 17875/Leb strain is a spontaneous mutant that
binds Leb but does not bind to sialylated antigens [15]. The panel of
99 clinical H. pylori isolates (including the series of SMI strains) came
from Uppsala University Hospital, Sweden, and have been described
previously [54]. Bacteria were grown on Brucella agar supplemented
with 10% bovine blood and 1% IsoVitalex (Svenska LABFAB, http://
www.labfab.se), for 43–48 h at 37 8C in 10% CO2 and 5% O2 before
harvest in phosphate-buffered saline (PBS) containing 0.05% Tween
20 and 1% BSA (Sigma-Aldrich, http://www.sigmaaldrich.com). E. coli
strains HB101/pPAP5 [47] and HB101/pAZZ50 [56] were cultured
overnight on Luria broth plates supplemented with chloramphenicol
and tetracycline.
Biopsies. Gastric biopsies harvested at endoscopy in human and
monkeys were ﬁxed in Z-ﬁx (10% paraformaldehyde þ 1% ionized
Zn; Anatech LTD, http://www.anatechltd.com), dehydrated, and
embedded in parafﬁn. The protocol involving human subjects was
approved by the Institutional Review Boards of the Veterans Affairs
New York Harbor Health Care System and the Uniformed Services
University of the Health Sciences, and written informed consent was
obtained from all patients before study entry. All animal experiments
were approved by the Armed Forces Radiobiology Research Institute
Institutional Animal Care and Use Committee and monitored and
reapproved at yearly intervals. All experiments were conducted
according to the principles set forth in the Guide for the Care and
Use of Laboratory Animals, Institute of Laboratory Animal Resour-
ces, National Research Council, (Washington, D. C.: National
Academy Press, 1996).
In situ hybridization. Sections (5 lm) were processed for in situ
hybridization [9]. Sections were ﬁrst deparafﬁnized in xylene,
rehydrated in graded ethanol, and treated with proteinase K. They
were then covered with hybridization mixture as described [9]. A
speciﬁc cDNA probe was designed using a sequence database for H.
pylori 16S rRNA [9], and the 59 end of the oligonucleotide was labeled
with biotin. The probe was denatured by heating for 10 min at 65 8C;
a drop of probe was then placed on the tissue, and the reaction was
incubated overnight at 37 8C for 18 h. The unbound probe was
removed by successive washes in decreasing concentrations of Na
citrate at room temperature and at 65 8C for the last wash. The
biotin-labeled probe was detected by streptavidin-conjugated alka-
line phosphatase (2 h of incubation at room temperature), and a
chromogenic substrate (nitro-blue-tetrazolium, NBT/BCIP kit; Vector
Labs, http://www.vectorlabs.com). After washing, sections were coun-
terstained with Nuclear Fast Red and mounted with permount.
Positive controls were as described [9] and included H. pylori pure
cultures streaked onto precleaned microscope slides. Negative
controls included E. coli and Shigella ﬂexneri cultures, and gastric
biopsy specimens from a 62-y-old H. pylori–negative patient with
dyspepsia were also used as negative controls [9]. Finally, control for
nonspeciﬁc binding was performed by using sense instead of
antisense probe, hybridization buffer instead of antisense probe,
unlabeled antisense probe, digoxigenin- or biotin-labeled probe for
the scorpion Buthus martensi Karsch neurotoxin sequence (59-GGC
CAC GCG TCG ACT AGT AC-39), RNase A pretreatment (Roche,
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plus DNase I pretreatment [9].
Epoxy (Spurr low viscosity) semithin sections stained with
toluidine blue. Biopsies were processed for transmission electron
microscopy using the conventional standard method [9]. Semithin
sections of 0.5 lm were stained with 1% toluidine blue.
Image acquisition. Sections were viewed using a light microscope
Nikon Eclipse E300 (http://www.nikon.com) and pictures were
captured and digitized using a QCapture camera (QImaging, http://
www.qimaging.com) and Micropublisher 5.0 RTV (QImaging).
HA conditions and reagents. Fresh human blood from a healthy
donor of blood group A phenotype was used for the HA assays. The
erythrocytes were washed twice with PBS. A 20% erythrocyte
suspension was treated at 28 8C with 0.05 or 0.1 mg/ml trypsin
(Sigma, http://www.sigmaaldrich.com) for 2 h at neutral pH [57]
followed by 1 mM phenylmethylsulfonylﬂuoride (PMSF; Sigma) for 15
min, and then gently washed ﬁve times with PBS. A 4% suspension of
trypsin-treated or untreated erythrocytes was incubated with
sialidase type VI from C. perfringens (Sigma) at 0.1 U/ml [26]. After
washing, a 0.75% erythrocyte suspension was mixed with a 2-fold
dilution series of H. pylori for estimation of sia-HA titers (i.e., the
reduction in HA titers as a result of sialidase treatment of
erythrocytes). Round-bottomed enzyme-linked immunosorbent assay
(ELISA) plates were used for the analysis, and the aggregation of
erythrocytes was determined visually after 1 h at room temperature
(23 8C).
Neoglycoproteins. All glycan conjugates used were semisynthetic
glycoproteins constructed of puriﬁed or chemically synthesized
oligosaccharides conjugated to either human serum albumin (HSA)
or to BSA (see Table 1). Leb, sLex, sdiLex, sLea, 39-sialyl-lactose, 69-
sialyl-lactose (IsoSep AB, http://www.isosep.com), and sLn (with three-
atom or 14-atom spacer, sLn(3) and sLn(14), respectively) glycocon-
jugates (Dextra Laboratories, http://www.dextra-labs.co.uk) were
labeled with
125I by the chloramine-T method [54]. The glycan
densities of the conjugates were 24 mol Leb oligosaccharides/mol
HSA, 13 mol sLex oligosaccharides/mol HSA, 11 mol sdiLex
oligosaccharides/mol HSA, 12 mol sLea oligosaccharides/mol HSA, 6
mol 39-sialyl-lactose oligosaccharides/mol HSA, 15 mol 69-sialyl-
lactose oligosaccharides/mol HSA, 11 mol sLn(3) oligosaccharides/
mol BSA, and 11 mol sLn(14) oligosaccharides/mol BSA.
Periodate oxidation of BSA blocking agent to destroy competitive
carbohydrate receptors for H. pylori binding. BSA (A3294; Sigma),
15% wt/vol in Milli-Q water (MQ; Millipore, http://www.millipore.-
com), was treated with 10 mM periodate for 1 h at pH 4.5. The
reaction mixture was then reduced with 20 mM Na2S2O5 (pH 6.7).
Reagents were removed by dialysis against MQ followed by PBS
containing 0.05% Tween 20 (PBS-Tween). Treated BSA was stored in
aliquots at  20 8C. BSA treated by periodate oxidation did not
quench sialyl binding, whereas the untreated BSA preparation
substantially reduced binding of the 17875babA1A2 mutant.
Analysis of H. pylori binding to soluble neoglycoproteins by
radioimmunoassay. For radioimmunoassay analyses, 1 ml of
bacteria (OD 600 nm ¼ 0.1) was mixed with 5 ng of
125I-labeled
conjugate. After 2 h at room temperature, the bacteria were
pelleted and bound conjugate was measured by gamma scintillation
counting (Wallac, http://las.perkinelmer.com) [54]. Binding experi-
ments were carried out in duplicate. To test the periodate-treated
BSA for presence of competitive carbohydrate receptors, bacteria
of strain SMI65 (OD 600 nm ¼ 0.1) were mixed with 2 ng of
125I-
labeled sdiLex conjugate and a dilution series of 0, 0.2, 0.4, 0.6, 0.8,
and 1% (wt/vol) periodate-treated or untreated BSA in PBS. After 2
h of incubation at room temperature, bacteria were pelleted and
bound conjugate was quantiﬁed as described above. The results
revealed that periodate-treated BSA did not inhibit sLex binding,
whereas the untreated BSA showed strong inhibition. The full
series of binding experiments reported in this study have been
performed by use of this deglycanated BSA-blocking agent.
Afﬁnity adsorption of SabA to erythrocyte surfaces. Bacteria were
harvested from overnight cultures, washed once with PBS, and then
treated with 500 ll deionized water for 15 min at room temperature
with gentle shaking. After centrifugation for 30 min at 10,000g at 4 8C,
103 PBS was added to the supernatant to bring it to 13 PBS. A total
of 200 ll of 4% erythrocyte suspension (with or without prior
sialidase treatment) was mixed 1:1 with bacterial protein extract for 1
h at room temperature. The erythrocytes were washed three times
with PBS, mixed with SDS-PAGE sample buffer, and heated for 5 min
at 95 8C. Electrophoresis was carried out using a 7.5% Tris-HCl Ready
gel (Bio-Rad Laboratories, http://www.bio-rad.com). For immunoblot
analysis, proteins were transferred to immunoblot polyvinylidene
diﬂuoride (PVDF) membranes (Bio-Rad). Membranes were blocked
for 1 h in PBS-Tween containing 5% nonfat dried milk. Antibodies
were raised in rabbit against full-length recombinant SabA as
previously described for BabA [58]. Blots were incubated with
horseradish peroxidase–conjugated goat anti-rabbit antibodies (Da-
ko, http://www.dako.com) diluted in PBS-Tween containing 1%
nonfat dried milk, and ﬁnally developed with SuperSignal West Pico
Chemiluminiscent Substrate (Pierce, http://www.piercenet.com).
Glycosphingolipids. Total non-acid and acid glycosphingolipid
fractions from human erythrocytes were obtained by standard
procedures [59]. Individual glycosphingolipids were isolated by
acetylation of total glycosphingolipid fractions and repeated chro-
matography on silicic acid columns. Acid glycosphingolipid fractions
were separated by DEAE-Sepharose chromatography, followed by
repeated silicic acid chromatography, and ﬁnal separation was
achieved by high-performance liquid chromatography. The identity
of the puriﬁed glycosphingolipids was conﬁrmed by mass spectrom-
etry [60], proton nuclear magnetic resonance spectroscopy [61], and
degradation studies [62,63]. A detailed description of the isolation
and characterization of the H. pylori–binding gangliosides has been
given elsewhere [45].
Chromatogram binding assay. The conditions used for culture,
35S-
labeling of H. pylori, and the chromatogram binding assays were as
described previously [36]. Mixtures of glycosphingolipids (40 lg/lane)
or pure compounds (1–4 lg/lane) were separated on aluminum-
backed silica gel 60 high-performance thin-layer chromatography
plates (Merck, http://merck.com) using chloroform/methanol/0.25%
KCl in water (50:40:10 by volume) as a solvent system. Thereafter, a
suspension of
35S-labeled bacteria (diluted in PBS to 1 3 10
8 CFU/ml
and 1–5 3 10
6 cpm/ml) was sprinkled over the chromatograms and
incubated for 2 h at room temperature. After washing with PBS and
drying, the thin-layer plates were autoradiographed using XAR-5 X-
ray ﬁlm (Eastman Kodak, http://www.kodak.com).
Analysis of binding afﬁnities for soluble glycoconjugates. The
afﬁnity for H. pylori SabA-mediated binding to sialylated glycoconju-
gates was measured by Scatchard analysis [37]. Each H. pylori strain
exhibits distinct binding afﬁnities for sialylated receptor structures.
Thus, for the afﬁnity analyses, the bacterial cells were diluted to
ascertain a free-to-bound ratio of conjugate binding close to 1.0
(equivalent to an equilibrium of ;50% bound glycoconjugate).
Unlabeled glycoconjugate was then added in a dilution series of
seven different concentrations, where the highest concentration was
predicted to block approximately 80% of glycoconjugate binding.
The bacterial cell–glycoconjugate mixture was incubated at room
temperature for 2 h in PBS-Tween with 1% of the periodate-treated
BSA as blocking agent. Bound conjugate was analyzed as described
above by gamma scintillation counting for 5 min.
Construction of sabA deletion mutants. To construct SMI14sabA::-
kan, SMI38sabA::cam, SMI100sabA::kan, and SMI31sabA::cam sabA
deletion mutants, the Swedish clinical isolates SMI14, SMI38,
SMI100, and SMI31 were ﬁrst single-colony puriﬁed and transformed
with sabA::kan or sabA::cam deletion vectors (previously described in
[15]). For construction of SMI9sabA::kan, sabA was ﬁrst PCR-ampliﬁed
using the primers M3F and M4R and cloned in the pBluescript SK
þ/ 
EcoRV site. The plasmid clone was then linearized with M7F and M5R
and ligated with the kanR gene, as described in [54]. H. pylori
transformants were analyzed for binding to
125I-labeled sLex
conjugate and for expression of SabA using anti-SabA antibodies,
as described above. The primer sequences were as follows: M3F (59-
CGCTAGTGTCCAGGGTAAC-39); M4R (59-TTGATCGTAAGG-
CAGTGTGATA-39); M7F (59-TCCCTAAAGATCAGTATCGT-39); and
M5R (59-CCGCGTATTGCGTTGGGTAG-39)
Construction of SMI9 sabAJ99 recombinants. The sabA gene of strain
J99 was ampliﬁed by PCR using primers J99-4F and J99-7R. The
resulting DNA fragment was transformed into strain SMI9sabA::kan.
Transformants expressing recombinant SabA were isolated by the
HA method as described below. Sequencing of sabA was performed
using primers sabA-278F and sabA-1136R. The primer sequences were
the following: J99-4F (59-GAATACGCAATCTTGTGGAGT-39); J99-7R
(59-CCAAATCACCCAATTACTTTG-39); sabA-278F (59-TACAACAG-
CACCACCCAA-39); and sabA-1136R (59-CATCTTTAGCCACGCT-
TAA-39).
HA method for enriching sialic acid–binding sabA recombinants.
For isolation of sialyl-binding transformants fresh human blood
from a healthy donor was used. The erythrocytes were washed three
times with PBS, and a 4% erythrocyte suspension was added onto 1
ml of bacterial transformation mixture (OD600 ¼ 1). The bacterial-
erythrocyte suspension was incubated with gentle rocking for 30 min
at 37 8C in 10% CO2 and 5% O2. For separation of transformants
with gained erythrocyte-associated (sialyl-binding) binding proper-
ties from the nonbinding (parent) SMI9sabA deletion mutant,
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removal of the supernatant and three rinses with PBS, 200 ll
Brucella broth was added and the suspension was spread on a
Brucella agar plate. Clones that express full-length SabA were
identiﬁed by colony screening as described below. The HA and
colony-screening procedure was repeated three times for efﬁcient
enrichment of clones of background strain SMI9, which had gained
in complementary expression of SabA from donor strain J99.
Colony screening for sialic acid–binding sabA recombinants. For
identiﬁcation of SabA-expressing clones the bacteria were spread in
serial dilutions onto Brucella agar plates and cultured until single
colonies appeared. The bacterial colonies were printed onto nitro-
cellulose membranes (Bio-Rad), which subsequently were soaked in
boiling hot 13sample buffer (4 ml 10% SDS, 1.6 ml Tris [pH 6.8], and
14.4 ml MQ H2O, with 500 ll b-mercaptoethanol) for 5 min. The
membranes were blocked overnight in TBS with 0.05% Tween 20
(TBS-Tween) containing 5% nonfat dried milk at 48C. SabA-
expressing clones were detected by using anti-SabA antibodies
(described above) and horseradish peroxidase–conjugated goat anti-
rabbit antibodies and ﬁnally visualized by using 4-chloro-1-naphtol
(4C1N) tablets (Sigma).
Construction of SMI9sabAJ99 sabA deletion mutants. In order to
construct SMI9sabAJ99::cam, SMI9sabAJ99 was transformed with a
sabA::cam deletion vector as described [14]. Chloramphenicol-
resistant transformants were analyzed for binding and expression
of SabA as described above.
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